Retrospective analysis was conducted to assess the presence of A faecalis infection, extensively drug-resistant A faecalis infection, and the susceptibility of commonly used antibiotics for the treatment of A faecalis and XDR A faecalis.
Investigators assessed the effect of mass distribution of azithromycin to preschool children on the gut resistome.
Investigators assessed whether a daily service of infectious disease consultation was more effective than weekly consultation to reduce antibiotic use without worsening clinical outcomes.
Study authors compared clinical cure in patients with E coli bacteremic UTI who were stepped down to oral beta-lactams compared to oral fluoroquinolones.
The COVID-19 Global Rheumatology Alliance Patient Experience Survey was used to assess the effect of antimalarial drug shortages during the COVID-19 pandemic.
Investigators assessed the incidence of acute kidney injury in patients requiring vancomycin and antipseudomonal agents, particularly comparing piperacillin-tazobactam vs cefepime in combination with vancomycin.
Metronidazole, vancomycin, fidaxomicin, meropenem, and piperacillin/tazobactam are rarely resistant to Clostridioides (Clostridium) difficile infection, while second-generation fluoroquinolones and clindamycin show highest risk.
Study authors assessed pneumococcal urinary antigen testing’s use in identifying patients for broad-spectrum antibiotic de-escalation, providing an opportunity for improved antimicrobial stewardship.
Investigators assessed the risk factors, prevalence, and epidemiology of carbapenemase-producing Enterobacteriacea in high-risk patients from ICU and HSCT wards.
The increased and inadequate use of linezolid prescriptions in a tertiary NICU and growing concerns of antimicrobial resistance are reviewed.
